Chronic wound patients face a number of challenges to their health and well-being. The presence of the ulcers is an indication of broader physical systems failures. However, with education and prevention, many wounds could be prevented or treated when they are less severe resulting in improved outcomes. The association between chronic conditions such as diabetes, cardiovascular disease, and social conditions is well established. Yet, none of the previous studies have addressed chronic ulcers. Healogics Wound Science Initiative is partnering with hospitals and researchers to better understand how the social determinants of health impact the lives of wounded patients.
Wound Science InitiativeThe Healogics Wound Science Initiative recognizes the value and relevance of data to drive continuous, collaborative learning towards a better understanding of how to efficiently utilize healthcare resources to effectively manage this growing population. Review data and insights from our research.
Measuring and reporting outcomes in wound care: The standardization conundrum – creating a new framework to define quality wound healing
The Healogics Wound Science Initiative is a collaborative effort that aims to accelerate data-driven improvements, advance insights and perspectives, and identify mechanisms to continuously improve patient outcomes and reduce costs in the treatment of chronic wounds. The Wound Science Initiative is committed to using the Healogics data to guide the creation of wound outcomes measures that allow for industry-wide standardization and aggregate quality benchmarking.
Etiology Specific Variation in Comprehensive Healing Rate and Time to Heal 2014-2017: Arterial, Diabetic, Pressure and Venous Ulcers
The purpose of this analysis is to examine the degree of variation in comprehensive healing rate and median time to heal for diabetic, arterial, pressure and venous ulcers using a modified intent-to-treat framework.
HBOT increases the dissolved oxygen content in blood plasma. Functionally speaking, this translates into a systemic increase in reactive oxygen (oxygen free radicals) and reactive nitrogen species. The direct result includes a number of physiological benefits to the wounded host.
This analysis presents findings from an external third-party analysis of the impact of hyperbaric oxygen therapy (HBOT) on diabetic ulcer outcomes, both healing and amputation, using a large sample of Healogics i-heal® data.
Quality of Care Would you send your mother or father to your wound care center? How many of your patients are getting healed and in how long? Efficiency, Cost and Utilization Is your wound center profitable? How productive is your current staff compared to national benchmarks? Are you using wound care supplies and consumables effectively?…
Wound healing outcomes: Using big data and a modified intent-to-treat method as a metric for reporting healing rates
This study presents a modified intent-to-treat framework for measuring wound outcomes and measures the consistency of population based outcomes across two distinct settings. In this retrospective observational analysis, we describe the largest to date, cohort of patient wound outcomes derived from 626 hospital based clinics and one academic tertiary care clinic. We present the results of a modified intent-to-treat analysis of wound outcomes as well as demographic and descriptive data.
A female in her fifties with a 1 year history of a non-healing medial right calf wound. According to patient, the wound was precipitated by an insect bite which resulted in a failed surgical closure. Patient has a significant history of HTN, osteoarthritis, fem-pop. bypass and right femoral angioplasty. Patient ambulates with a walker and brace support and has significant financial limitations due to inability to work.
The prevalence of lower extremity venous disease in our population is greater than that of peripheral arterial occlusive disease, although the latter receives more attention. An estimated 35 percent of the adult population has lower extremity venous abnormalities and one-fifth of these individuals will acquire one or more venous ulcers in their lifetime.